178 related articles for article (PubMed ID: 10371752)
21. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
[TBL] [Abstract][Full Text] [Related]
22. Effect of potassium citrate therapy on the risk of renal stone formation during spaceflight.
Whitson PA; Pietrzyk RA; Jones JA; Nelman-Gonzalez M; Hudson EK; Sams CF
J Urol; 2009 Nov; 182(5):2490-6. PubMed ID: 19765769
[TBL] [Abstract][Full Text] [Related]
23. Comparison between lemonade and potassium citrate and impact on urine pH and 24-hour urine parameters in patients with kidney stone formation.
Koff SG; Paquette EL; Cullen J; Gancarczyk KK; Tucciarone PR; Schenkman NS
Urology; 2007 Jun; 69(6):1013-6. PubMed ID: 17572176
[TBL] [Abstract][Full Text] [Related]
24. [Diagnosis, prevention and treatment of renal and urinary tract lithiasis].
Tamayo JA; Peña JC
Gac Med Mex; 1990; 126(6):497-505; discussion 505-7. PubMed ID: 2103559
[TBL] [Abstract][Full Text] [Related]
25. Insulin resistance and low urinary citrate excretion in calcium stone formers.
Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
[TBL] [Abstract][Full Text] [Related]
26. Urinary phytate in calcium oxalate stone formers and healthy people--dietary effects on phytate excretion.
Grases F; March JG; Prieto RM; Simonet BM; Costa-Bauzá A; García-Raja A; Conte A
Scand J Urol Nephrol; 2000 Jun; 34(3):162-4. PubMed ID: 10961468
[TBL] [Abstract][Full Text] [Related]
27. [Indicators of the risk of calcium oxalate urinary calculi: comparative study of the Parks' and Tiselius' indices, urinary citrate/calciuria ratio, and morning crystalluria].
Robert M; Boularan AM; Guiter J; Monnier L
Prog Urol; 1996 Apr; 6(2):264-8. PubMed ID: 8777421
[TBL] [Abstract][Full Text] [Related]
28. [Effect of potassium citrate in the prophylaxis of urinary lithiasis].
Jiménez Verdejo A; Arrabal Martín M; Miján Ortiz JL; Hita Rosino E; Palao Yago F; Zuluaga Gómez A
Arch Esp Urol; 2001 Nov; 54(9):1036-46. PubMed ID: 11789361
[TBL] [Abstract][Full Text] [Related]
29. Metabolic abnormalities associated with calyceal diverticular stones.
Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
[TBL] [Abstract][Full Text] [Related]
30. Lemonade therapy increases urinary citrate and urine volumes in patients with recurrent calcium oxalate stone formation.
Penniston KL; Steele TH; Nakada SY
Urology; 2007 Nov; 70(5):856-60. PubMed ID: 17919696
[TBL] [Abstract][Full Text] [Related]
31. Effects of inositol hexaphosphate (phytate) on calcium binding, calcium oxalate crystallization and in vitro stone growth.
Saw NK; Chow K; Rao PN; Kavanagh JP
J Urol; 2007 Jun; 177(6):2366-70. PubMed ID: 17509360
[TBL] [Abstract][Full Text] [Related]
32. [Citrate (CG-120) therapy for urolithiasis. 1. Clinical effects].
Ohkawa T; Ebisuno S; Morimoto S; Yasukawa S; Sonoda T; Koide T; Oka T; Aso Y; Higashihara E; Kitagawa R
Hinyokika Kiyo; 1988 May; 34(5):905-17. PubMed ID: 3051945
[TBL] [Abstract][Full Text] [Related]
33. [Calcium oxalate lithiasis. Relationship between biochemical risk factors and crystalline phase of the stone].
Parent X; Boess G; Brignon P
Prog Urol; 1999 Dec; 9(6):1051-6. PubMed ID: 10658250
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of Mixtures of Magnesium, Citrate and Phytate as Calcium Oxalate Crystallization Inhibitors in Urine.
Grases F; Rodriguez A; Costa-Bauza A
J Urol; 2015 Sep; 194(3):812-9. PubMed ID: 25818031
[TBL] [Abstract][Full Text] [Related]
35. [Biochemical effects of potassium citrate in the treatment of calcium oxalate lithiasis].
Conte Visús A; Ibarz Servio L; Arrabal Martín M; Ibarz Navarro JM; Ruiz Marcellán FJ
Arch Esp Urol; 1994 Mar; 47(2):141-50. PubMed ID: 8002670
[TBL] [Abstract][Full Text] [Related]
36. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.
Pak CY; Heller HJ; Pearle MS; Odvina CV; Poindexter JR; Peterson RD
J Urol; 2003 Feb; 169(2):465-9. PubMed ID: 12544288
[TBL] [Abstract][Full Text] [Related]
37. [The most important factor for active urinary stone formation in patients with urolithiasis].
Simić-Ogrizović S; Dopsaj V; Jovicić S; Milenković D; Jovanović D; Nesić V
Med Pregl; 2007; 60 Suppl 2():117-20. PubMed ID: 18928175
[TBL] [Abstract][Full Text] [Related]
38. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women.
Sakhaee K; Poindexter JR; Griffith CS; Pak CY
J Urol; 2004 Sep; 172(3):958-61. PubMed ID: 15311008
[TBL] [Abstract][Full Text] [Related]
39. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones?
Laube N; Jansen B; Hesse A
Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124
[TBL] [Abstract][Full Text] [Related]
40. Effects of calcium supplements on the risk of renal stone formation in a population with low oxalate intake.
Stitchantrakul W; Sopassathit W; Prapaipanich S; Domrongkitchaiporn S
Southeast Asian J Trop Med Public Health; 2004 Dec; 35(4):1028-33. PubMed ID: 15916110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
